Product Substitution For Excedrin Announced
USProduct Substitution For Excedrin Announced
Recalling Firm: Excedrin, Bristol Myers
Reason for Recall / Hazard
Poisoning
Product Description & Identification
Product Substitution For Excedrin Announced NEWS from CPSC U.S. Consumer Product Safety Commission Office of Information and Public Affairs Washington, DC 20207 FOR IMMEDIATE RELEASE June 7, 1977 Release # 77-059 Product Substitution For Excedrin Announced WASHINGTON, D.C. (June 7) -- Bristol Myers Products, a division of Bristol Myers Company, and the Consumer Product Safety Commission (CPSC) announced today a product substitution of the company's 225 tablet package size and 375 tablet size of Excedrin analgesic tablets which were distributed nationwide prior to April 1977. CPSC testing found same packages for this product failed to comply with Federal regulations requiring that the packages be child-resistant. The product substitution covers warehouse inventories of those major wholesale and retail customers handling approximately 81% of the merchandise. Existing inventories of these packages are being retrieved and replaced by upgraded packages which were tested by Bristol Myers to assure CPSC compliance. The product substitution will involve approximately 150,000 packages and will be completed by the middle of June. These two sizes represent less than 3% of Excedrin analgesic annual unit sales volume. Bristol Myers Products, in addition, has improved its packages for these sizes of Excedrin analgesic products and has expanded its quality control program to reduce the likelihood of similar situations arising in the future. This program is not a substitute for any legal action which may be deemed necessary by CPSC.
Affected Products
Bristol Myers Excedrin
Additional Source Details
| Field | Value |
|---|---|
| U R L | https://www.cpsc.gov/Recalls/1977/Product-Substitution-For-Excedrin-Announced |
| Title | Product Substitution For Excedrin Announced |
| Hazards › Name | Poisoning |
| Products › Name | Bristol Myers Excedrin |
| Products › Type | Medication |
| Products › Category I D | 2043 |
| Recall I D | 3895 |
| Recall Date | 1977-06-07T00:00:00 |
| Description | Product Substitution For Excedrin Announced NEWS from CPSC U.S. Consumer Product Safety Commission Office of Information and Public Affairs Washington, DC 20207 FOR IMMEDIATE RELEASE June 7, 1977 Release # 77-059 Product Substitution For Excedrin Announced WASHINGTON, D.C. (June 7) -- Bristol Myers Products, a division of Bristol Myers Company, and the Consumer Product Safety Commission (CPSC) announced today a product substitution of the company's 225 tablet package size and 375 tablet size of Excedrin analgesic tablets which were distributed nationwide prior to April 1977. CPSC testing found same packages for this product failed to comply with Federal regulations requiring that the packages be child-resistant. The product substitution covers warehouse inventories of those major wholesale and retail customers handling approximately 81% of the merchandise. Existing inventories of these packages are being retrieved and replaced by upgraded packages which were tested by Bristol Myers to assure CPSC compliance. The product substitution will involve approximately 150,000 packages and will be completed by the middle of June. These two sizes represent less than 3% of Excedrin analgesic annual unit sales volume. Bristol Myers Products, in addition, has improved its packages for these sizes of Excedrin analgesic products and has expanded its quality control program to reduce the likelihood of similar situations arising in the future. This program is not a substitute for any legal action which may be deemed necessary by CPSC. |
| Recall Number | 77059 |
| Manufacturers › 1 › Name | Excedrin |
| Manufacturers › 2 › Name | Bristol Myers |
| Last Publish Date | 2015-02-04T00:00:00 |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmExcedrin, Bristol Myers
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Excedrin, Bristol Myers - Product Substitution For Excedrin Announced Check if your household is affected: https://therecallfile.com/recalls/product-substitution-for-excedrin-announced/CPSC-77059
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Featured on Product Hunt
Help support our public safety mission and check out our community launch.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Related Recalls
Health CanadaTransport Canada Recall - 2018088 -
Transport Canada Recall - 2018088 -
Tires
Health CanadaTransport Canada Recall - 2018288 -
Transport Canada Recall - 2018288 -
Airbag
Health CanadaTransport Canada Recall - 2018409 -
Transport Canada Recall - 2018409 -
Airbag